Raphaela Schwentner

8PUBLICATIONS
24CO-AUTHORS
AutoimmunityHaematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 04, 2024
BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responses.

Giulio Abagnale, Raphaela Schwentner, Philipp Ben Soussia-Weiss

|Oct 07, 2021
Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis.

Sebastian K Eder, Raphaela Schwentner, Philipp Ben Soussia

|Jan 09, 2021
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.

Lisa Bierbaumer, Anna M Katschnig, Branka Radic-Sarikas

|Jul 27, 2019
Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.

Florian Halbritter, Matthias Farlik, Raphaela Schwentner

|Oct 09, 2018
JAG2 signaling induces differentiation of CD14+ monocytes into Langerhans cell histiocytosis-like cells.

Raphaela Schwentner, Gunhild Jug, Maximilian O Kauer

|Jul 11, 2017
Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.

Petra van der Lelij, Simone Lieb, Julian Jude

Pageof 2